CRBU
CRBU
NASDAQ · Biotechnology

Caribou Biosciences Inc

$1.99
+0.09 (+4.74%)
As of Apr 1, 10:08 PM ET ·
Financial Highlights (FY 2026)
Revenue
12.39M
Net Income
-164,470,603
Gross Margin
Profit Margin
-1,327.4%
Rev Growth
-7.0%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 33.4% 33.4%
Operating Margin -1,411.4% -1,270.3% 20.5% 22.4%
Profit Margin -1,327.4% -1,261.0% 18.2% 16.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 12.39M 13.32M 54.83M 47.58M
Gross Profit 18.34M 15.91M
Operating Income -174,898,040 -169,165,218 11.25M 10.65M
Net Income -164,470,603 -159,079,573 10.00M 7.87M
Gross Margin 33.4% 33.4%
Operating Margin -1,411.4% -1,270.3% 20.5% 22.4%
Profit Margin -1,327.4% -1,261.0% 18.2% 16.6%
Rev Growth -7.0% -7.0% -2.4% +14.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 60.52M 50.56M
Total Equity 94.36M 88.94M
D/E Ratio 0.64 0.57
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -161,038,300 -164,413,095 16.80M 15.25M
Free Cash Flow 9.93M 9.62M